References
- IDF Diabetes Atlas [Internet]. [cited 2018 May 27]. Available from: https://www.idf.org/e-library/epidemiology-research/diabetes-atlas.html
- International Diabetes Federation-Gestational diabetes [Internet]. [cited 2018 May 27]. Available from: https://www.idf.org/our-activities/care-prevention/gdm
- Miller E, Hare JW, Cloherty JP, et al. Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med. 1981;304:1331–1334.
- Lucas MJ, Leveno KJ, Williams ML, et al. Early pregnancy glycosylated hemoglobin, severity of diabetes, and fetal malformations. Am J Obstet Gynecol. 1989;161:426–431.
- Temple R, Aldridge V, Greenwood R, et al. Association between outcome of pregnancy and glycaemic control in early pregnancy in type 1 diabetes: population based study. BMJ. 2002;325:1275–1276.
- Creasy and Resnik’s maternal-fetal medicine: principles and practice – 7th ed. [Internet]. [cited 2018 May 28]. Available from: https://www.elsevier.com/books/creasy-and-resniks-maternal-fetal-medicine-principles-and-practice/resnik/978-1-4557-1137-6
- Lawrence JM, Contreras R, Chen W, et al. Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005. Diabetes Care. 2008;31:899–904.
- Albrecht SS, Kuklina EV, Bansil P, et al. Diabetes trends among delivery hospitalizations in the U.S., 1994-2004. Diabetes Care. 2010;33:768–773.
- Kitzmiller JL, Buchanan TA, Siri K, et al. Pre-conception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care. 1996;19:514–541.
- American College of Obstetricians and Gynecologists Committee on Practice Bulletins–Obstetrics. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. Obstet Gynecol. 2001;98:525–538.
- U.S. Preventive Services Task Force. Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008 20;148:759–765.
- HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;8358:1991–2002.
- Committee on Practice Bulletins–Obstetrics. Practice Bulletin No. 137: Gestational diabetes mellitus. Obstet Gynecol. 2013;122:406–416.
- HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes. 2009;58:453–459.
- Hauguel S, Desmaizieres V, Challier JC. Glucose uptake, utilization, and transfer by the human placenta as functions of maternal glucose concentration. Pediatr Res. 1986;20:269–273.
- Carstensen M, Leichweiss HP, Molsen G, et al. Evidence for a specific transport of D-hexoses across the human term placenta in vitro. Arch Gynakol. 1977;222:187–196.
- Challier JC, Nandakumaran M, Mondon F. Placental transport of hexoses: a comparative study with antipyrine and amino acids. Placenta. 1985;6:497–504.
- Rice PA, Rourke JE, Nesbitt RE. In vitro perfusion studies of the human placenta. VI. Evidence against active glucose transport. Am J Obstet Gynecol. 1979;133:649–655.
- Rice PA, Rourke JE, Nesbitt EL. In vitro perfusion studies of the human placenta. IV. Some characteristics of the glucose transport system in the human placenta. Gynecol Obstet Invest. 1976;7:213–221.
- Widdas WF. Inability of diffusion to account for placental glucose transfer in the sheep and consideration of the kinetics of a possible carrier transfer. J Physiol (Lond). 1952;118:23–39.
- Jansson T, Ylvén K, Wennergren M, et al. Glucose transport and system A activity in syncytiotrophoblast microvillous and basal plasma membranes in intrauterine growth restriction. Placenta. 2002;23:392–399.
- Jansson T, Wennergren M, Illsley NP. Glucose transporter protein expression in human placenta throughout gestation and in intrauterine growth retardation. J Clin Endocrinol Metab. 1993;77:1554–1562.
- Jansson T, Wennergren M, Powell TL. Placental glucose transport and GLUT 1 expression in insulin-dependent diabetes. Am J Obstet Gynecol. 1999;180:163–168.
- Pedersen J. The Pregnant Diabetic and Her Newborn: Problems and Management. 2nd ed. Copenhagen: Williams & Wilkins; 1977. 280 p.
- Ogata ES, Sabbagha R, Metzger BE, et al. Serial ultrasonography to assess evolving fetal macrosomia. Studies in 23 pregnant diabetic women. JAMA. 1980 Jun 20;243:2405–2408.
- Paine LL. Obstetrics: normal and problem pregnancies. Edited by: Steven G. Gabbe, Jennifer R. Niebyl, and Joe L. Simpson. New York: Churchill Livingstone, 1986. 1148 pages. $75.00, hardcover. Journal of Nurse-Midwifery. 33(6):290–291.
- Miodovnik M, Lavin JP, Knowles HC, et al. Spontaneous abortion among insulin-dependent diabetic women. Am J Obstet Gynecol. 1984;15;150:372–376.
- Jovanovic L, Knopp RH, Kim H, et al. Elevated pregnancy losses at high and low extremes of maternal glucose in early normal and diabetic pregnancy: evidence for a protective adaptation in diabetes. Diabetes Care. 2005;28:1113–1117.
- Hollingsworth DR, Cousins L. Diabetes in pregnancy: a new perspective. New York (NY): Plenum Press. 1981;
- Nold JL, Georgieff MK. Infants of diabetic mothers. Pediatr Clin North Am. 2004;51:619–637.
- Tyrala EE. The infant of the diabetic mother. Obstet Gynecol Clin North Am. 1996;23:221–241.
- Cordero L, Treuer SH, Landon MB, et al. Management of infants of diabetic mothers. Arch Pediatr Adolesc Med. 1998;152:249–254.
- Yang J, Cummings EA, O’Connell C, et al. Fetal and neonatal outcomes of diabetic pregnancies. Obstet Gynecol. 2006;108:644–650.
- Becerra JE, Khoury MJ, Cordero JF, et al. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics. 1990;85:1–9.
- Correa A, Gilboa SM, Besser LM, et al. Diabetes mellitus and birth defects. Am J Obstet Gynecol. 2008;199:237.e1–239.
- Persson M, Fadl H, Hanson U, et al. Disproportionate body composition and neonatal outcome in offspring of mothers with and without gestational diabetes mellitus. Diabetes Care. 2013;36:3543–3548.
- Persson M, Pasupathy D, Hanson U, et al. Birth size distribution in 3,705 infants born to mothers with type 1 diabetes: a population-based study. Diabetes Care. 2011;34:1145–1149.
- Ballard JL, Rosenn B, Khoury JC, et al. Diabetic fetal macrosomia: significance of disproportionate growth. J Pediatr. 1993;122:115–119.
- McFarland MB, Trylovich CG, Langer O. Anthropometric differences in macrosomic infants of diabetic and nondiabetic mothers. J Matern Fetal Med. 1998;7:292–295.
- Schwartz R, Gruppuso PA, Petzold K, et al. Hyperinsulinemia and macrosomia in the fetus of the diabetic mother. Diabetes Care. 1994;17:640–648.
- Salvesen DR, Brudenell JM, Proudler AJ, et al. Fetal pancreatic beta-cell function in pregnancies complicated by maternal diabetes mellitus: relationship to fetal acidemia and macrosomia. Am J Obstet Gynecol. 1993;168:1363–1369.
- Radaelli T, Lepercq J, Varastehpour A, et al. Differential regulation of genes for fetoplacental lipid pathways in pregnancy with gestational and type 1 diabetes mellitus. Am J Obstet Gynecol. 2009;201:209.e1–209.e10.
- Ong K, Kratzsch J, Kiess W, et al. Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. J Clin Endocrinol Metab. 2000;85:4266–4269.
- Roth S, Abernathy MP, Lee WH, et al. Insulin-like growth factors I and II peptide and messenger RNA levels in macrosomic infants of diabetic pregnancies. J Soc Gynecol Investig. 1996;3:78–84.
- Vohr BR, McGarvey ST, Coll CG. Effects of maternal gestational diabetes and adiposity on neonatal adiposity and blood pressure. Diabetes Care. 1995;18:467–475.
- Van Assche FA, Holemans K, Aerts L. Long-term consequences for offspring of diabetes during pregnancy. Br Med Bull. 2001;60:173–182.
- Nesbitt TS, Gilbert WM, Herrchen B. Shoulder dystocia and associated risk factors with macrosomic infants born in California. Am J Obstet Gynecol. 1998;179:476–480.
- Athukorala C, Crowther CA, Willson K. Austrailian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Women with gestational diabetes mellitus in the ACHOIS trial: risk factors for shoulder dystocia. Aust N Z J Obstet Gynaecol. 2007;47:37–41.
- Moore TR. A comparison of amniotic fluid fetal pulmonary phospholipids in normal and diabetic pregnancy. Am J Obstet Gynecol. 2002;186:641–650.
- Hornberger LK. Maternal diabetes and the fetal heart. Heart. 2006;92:1019–1021.
- Mace S, Hirschfield SS, Riggs T, et al. Echocardiographic abnormalities in infants of diabetic mothers. J Pediatr. 1979;95:1013–1019.
- Hardt SE, Sadoshima J. Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development. Circ Res. 2002;90:1055–1063.
- Jaeggi ET, Fouron JC, Proulx F. Fetal cardiac performance in uncomplicated and well-controlled maternal type I diabetes. Ultrasound Obstet Gynecol. 2001;17:311–315.
- Pollex E, Moretti ME, Koren G, et al. Safety of insulin glargine use in pregnancy: a systematic review and meta-analysis. Ann Pharmacother. 2011;45:9–16.
- Cornblath M, Hawdon JM, Williams AF, et al. Controversies regarding definition of neonatal hypoglycemia: suggested operational thresholds. Pediatrics. 2000;105:1141–1145.
- Miodovnik M, Mimouni F, Tsang RC, et al. Management of the insulin-dependent diabetic during labor and delivery. Amer J Perinatol. 1987;4:106–114.
- Andersen GE, Hertel J, Kühl C, et al. Metabolic events in infants of diabetic mothers during first 24 hours after birth. II. Changes in plasma lipids. Acta Paediatr Scand. 1982;71:27–32.
- Mimouni F, Miodovnik M, Siddiqi TA, et al. Neonatal polycythemia in infants of insulin-dependent diabetic mothers. Obstet Gynecol. 1986;68:370–372.
- Oden J, Bourgeois M. Neonatal endocrinology. Indian J Pediatr. 2000;67:217–223.
- Mimouni F, Loughead J, Miodovnik M, et al. Early neonatal predictors of neonatal hypocalcemia in infants of diabetic mothers: an epidemiologic study. Am J Perinatol. 1990;7:203–206.
- Tsang RC. Neonatal Magnesium Disturbances. Am J Dis Child. 1972; 1124:282–293.
- Mimouni F, Miodovnik M, Tsang RC, et al. Decreased maternal serum magnesium concentration and adverse fetal outcome in insulin-dependent diabetic women. Obstet Gynecol. 1987;70:85–88.
- Freitag JJ, Martin KJ, Conrades MB, et al. Evidence for skeletal resistance to parathyroid hormone in magnesium deficiency. J Clin Invest. 1979;64:1238–1244.
- Silverman BL, Metzger BE, Cho NH, et al. Impaired glucose tolerance in adolescent offspring of diabetic mothers. Relationship to fetal hyperinsulinism. Diabetes Care. 1995;18:611–617.
- Silverman BL, Rizzo T, Green OC, et al. Long-term prospective evaluation of offspring of diabetic mothers. Diabetes. 1991;40 Suppl.2:121–125.
- Pettitt DJ, Aleck KA, Baird HR, et al. Congenital susceptibility to NIDDM. Role of intrauterine environment. Diabetes. 1988;37:622–628.
- Dabelea D, Hanson RL, Bennett PH, et al. Increasing prevalence of Type II diabetes in American Indian children. Diabetologia. 1998;41:904–910.
- Fetita L-S, Sobngwi E, Serradas P, et al. Consequences of fetal exposure to maternal diabetes in offspring. J Clin Endocrinol Metab. 2006;91:3718–3724.
- Plagemann A. “Fetal programming” and “functional teratogenesis”: on epigenetic mechanisms and prevention of perinatally acquired lasting health risks. J Perinat Med. 2004;32:297–305.
- Serradas P, Goya L, Lacorne M, et al. Fetal insulin-like growth factor-2 production is impaired in the GK rat model of type 2 diabetes. Diabetes. 2002;51:392–397.
- Amri K, Freund N, Vilar J, et al. Adverse effects of hyperglycemia on kidney development in rats: in vivo and in vitro studies. Diabetes. 1999;48:2240–2245.
- Nelson RG, Morgenstern H, Bennett PH. Intrauterine diabetes exposure and the risk of renal disease in diabetic Pima Indians. Diabetes. 1998;47:1489–1493.
- Clausen TD, Mathiesen ER, Hansen T, et al. Overweight and the metabolic syndrome in adult offspring of women with diet-treated gestational diabetes mellitus or type 1 diabetes. J Clin Endocrinol Metab. 2009;94:2464–2470.
- Larger E, Marre M, Corvol P, et al. Hyperglycemia-induced defects in angiogenesis in the chicken chorioallantoic membrane model. Diabetes. 2004;53:752–761.
- Pinter E, Haigh J, Nagy A, et al. Hyperglycemia-induced vasculopathy in the murine conceptus is mediated via reductions of VEGF-A expression and VEGF receptor activation. Am J Pathol. 2001;158:1199–1206.
- Stehbens JA, Baker GL, Kitchell M. Outcome at ages 1, 3, and 5 years of children born to diabetic women. Am J Obstet Gynecol. 1977;127:408–413. 15
- Ornoy A, Ratzon N, Greenbaum C, et al. School-age children born to diabetic mothers and to mothers with gestational diabetes exhibit a high rate of inattention and fine and gross motor impairment. J Pediatr Endocrinol Metab. 2001;14: 681–689.
- Breitweser JA, Meyer RA, Sperling MA, et al. Cardiac septal hypertrophy in hyperinsulinemic infants. J Pediatr. 1980;96:535–539.
- Hay WW, Raju TN, Higgins RD, et al. Knowledge gaps and research needs for understanding and treating neonatal hypoglycemia: workshop report from Eunice Kennedy Shriver National Institute of Child Health and Human Development. J Pediatr. 2009;155:612–617.
- Adamkin DH. Committee on Fetus and Newborn. Postnatal glucose homeostasis in late-preterm and term infants. Pediatrics. 2011;127:575–579.
- Kallem VR, Pandita A, Gupta G. Hypoglycemia: when to treat? Clin Med Insights Pediatr. 2017;11:11795565177489131179556517748913.
- Ozek E, Soll R, Schimmel MS. Partial exchange transfusion to prevent neurodevelopmental disability in infants with polycythemia. Cochrane Database Syst Rev. 2010;CD005089. doi:10.1002/14651858.CD005089.pub2.
- Mimouni FB, Merlob P, Dollberg S, Israeli Neonatal Association, et al. Neonatal polycythaemia: critical review and a consensus statement of the Israeli Neonatology Association. Acta Paediatr. 2011;100:1290–1296.